Windtree names Jamie McAndrew CAO; grants equity to CEO and CMO

WINDTREE THERAPEUTICS INC /DE/

Jamie McAndrew appointed VP, Controller & Chief Accounting Officer effective Aug 24, 2023.
McAndrew receives $301K base salary with 30% target bonus.
CEO Craig Fraser awarded options for 68,800 shares at $1.21 strike and RSUs 45,867.
CMO Steven Simonson awarded options for 23,800 shares at $1.21 strike and RSUs 15,867.
Options and RSUs vest in three equal annual installments.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jamie McAndrew

Vice President, Controller & Chief Accounting Officer

WINT · WINDTREE THERAPEUTICS INC /DE/

Effective: 2023-08-24
Filed: August 28, 2023, 7:59 PM ET

Effective August 24, 2023, the Board of Directors (the “ Board ”) of Windtree Therapeutics, Inc. (the “ Company ”) appointed Jamie McAndrew as Vice President, Controller & Chief Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jamie McAndrew was appointed as Vice President, Controller & Chief Accounting Officer at WINDTREE THERAPEUTICS INC /DE/.

Action: appointed
Role: Vice President, Controller & Chief Accounting Officer

Exact text from the filing

Effective August 24, 2023, the Board of Directors (the “ Board ”) of Windtree Therapeutics, Inc. (the “ Company ”) appointed Jamie McAndrew as Vice President, Controller & Chief Accounting Officer.

View on SEC.gov

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-23-024764

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.